Novo CEO pressed by Senate to cut rates of obesity, diabetic issues medicines CEO Lars Fruergaard Jørgensen told lawmakers the corporation would think about new talks with insurers regarding the listing prices of Wegovy and copyright when they pledge to help keep the medicines on their own formularies. Elevance lowers https://labelthefigurewiththeitem30739.smblogsites.com/30650321/5-essential-elements-for-healthcare-news